Evaluating the clinical utility of the patient‐identified most bothersome symptom measure from PROMISE‐2 for research in migraine prevention-Reference-Cited by-同舟云学术

Evaluating the clinical utility of the patient‐identified most bothersome symptom measure from PROMISE‐2 for research in migraine prevention

Published:2022-04-25 Issue:6 Volume:62 Page:690-699
ISSN:0017-8748
Container-title:Headache: The Journal of Head and Face Pain
language:en
Short-container-title:Headache

Author:

Lipton Richard B.¹,Goadsby Peter J.²³,Dodick David W.⁴^ORCID,McGinley James S.⁵,Houts Carrie R.⁵,Wirth R. J.⁵,Kymes Steve⁶,Ettrup Anders⁷,Østerberg Ole⁷,Cady Roger⁸,Ashina Messoud⁹^ORCID,Buse Dawn C.¹⁵

Affiliation:

1. Department of Neurology Albert Einstein College of Medicine Bronx New York USA

2. NIHR‐Wellcome Trust King’s Clinical Research Facility King’s College Hospital London UK

3. Department of Neurology University of California Los Angeles California USA

4. Mayo Clinic Phoenix Arizona USA

5. Vector Psychometric Group, LLC Chapel Hill North Carolina USA

6. Lundbeck LLC Deerfield Illinois USA

7. H. Lundbeck A/S Copenhagen Denmark

8. RK Consults, LLC Ozark Missouri USA

9. Danish Headache Center Rigshospitalet Glostrup University of Copenhagen Copenhagen Denmark

Funder

H. Lundbeck A/S

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/head.14295

Reference30 articles.

1. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition

2. Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II

3. Migraine Symptoms: Results of a Survey of Self-Reported Migraineurs

4. Cognitive dysfunction and migraine

5. Pathophysiology of Migraine: A Disorder of Sensory Processing

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leveraging patient-reported outcome measures for optimal dose selection in early phase cancer trials (Preprint);2024-07-24

2. Headache/migraine-related stigma, quality of life, disability, and most bothersome symptom in adults with current versus previous high-frequency headache/migraine and medication overuse: results of the Migraine Report Card survey;BMC Neurology;2024-07-04

3. Characterizing neck pain during headache among people with migraine: Multicountry results from the Chronic Migraine Epidemiology and Outcomes – International (CaMEO‐I) cross‐sectional study;Headache: The Journal of Head and Face Pain;2024-06-22

4. A real‐world prospective observational study of eptinezumab in Asian patients with migraine;Headache: The Journal of Head and Face Pain;2024-05-24

5. Eptinezumab for the preventive treatment of episodic and chronic migraine: a narrative review;Frontiers in Neurology;2024-03-08